Simplex Trading’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Simplex Trading’s Portfolio CASC Stock Details CASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-14	Closed	-$1K	–	7015
2016 Q3	$1K	Sell	14 -65	-82%	-$461	﹤0.01%	5610
2016 Q2	$1K	Buy	+79	New	+$536	﹤0.01%	5612
2016 Q1	–	Sell	-9	Closed	-$4K	–	6741
2015 Q4	$4K	Sell	9 -17	-65%	-$293	﹤0.01%	4124
2015 Q3	$6K	Sell	26 -26	-50%	-$533	﹤0.01%	3915
2015 Q2	$44K	Buy	+52	New	+$822	﹤0.01%	1795
2015 Q1	–	Sell	-16	Closed	-$1K	–	6021
2014 Q4	$1K	Buy	+16	New	+$174	﹤0.01%	4447

Simplex Trading's CASC Position: Q1 2018 in Review

Simplex Trading sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 218 shares.

Simplex Trading first reported a position in CASC in Q4 2015 and held it in 8 quarters. The position peaked at $35K in Q1 2016. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

Simplex Trading reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Simplex Trading sold 218 Cascadian Therapeutics, Inc. shares in Q1 2018.
Simplex Trading first reported a position in Cascadian Therapeutics, Inc. in Q4 2015 and held it in 8 quarters.
Simplex Trading's Cascadian Therapeutics, Inc. position peaked at $35K in Q1 2016.
1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on Simplex Trading's 13F filing for Q1 2018, filed 26 Apr 2018.